Format

Send to

Choose Destination
Cornea. 2002 Nov;21(8):838-9.

The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma.

Author information

1
Hong Kong Eye Hospital, Hospital Authority Ophthalmic Services, Hong Kong, People's Republic of China.

Abstract

PURPOSE:

To describe the use of postoperative topical mitomycin C (MMC) in the treatment of recurrent conjunctival papilloma.

METHODS:

Case report.

RESULTS:

We report a 26-year-old man with recurrent conjunctival papilloma despite repeated surgical excision, cauterization, and cryotherapy. He was then treated with excision by cryotherapy, followed by a 2-week course of topical MMC eyedrops prescribed at postoperative day 7 (0.02 mg/mL, four times daily). No recurrence was observed 24 months postoperatively, and no complication was observed during the follow-up period.

CONCLUSION:

Postoperative topical MMC may be a useful adjunct in the management of recurrent conjunctival papilloma.

PMID:
12410049
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center